Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Propeto is a high-purity white petrolatum formulation developed and marketed by Maruho Co., Ltd. in Japan. It functions as an occlusive emollient that forms a protective, hydrophobic barrier on the skin's surface, effectively preventing transepidermal water loss (TEWL) and shielding the stratum corneum from external irritants. It is primarily indicated for the treatment of dry skin conditions such as asteatosis (sebum deficiency), eczema, and various forms of dermatitis. Propeto is distinguished from standard white petrolatum by a specialized purification process that removes impurities such as polar compounds and oxidative products, which are known to cause skin irritation or contact dermatitis. This high level of purity makes it particularly suitable for patients with sensitive skin, pediatric populations, and application to delicate areas like the face or eyelids.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on white petrolatum.